Article
Spectrum of mutations in leiomyosarcomas identified by clinical targeted next-generation sequencing.
Experimental and molecular pathology - 1 Feb 2017
Lee Paul J, Yoo Naomi S, Hagemann Ian S, Pfeifer John D, Cottrell Catherine E, Abel Haley J, Duncavage Eric J
Abstract excerpt
Recurrent genomic mutations in uterine and non-uterine leiomyosarcomas have not been well established. Using a next generation sequencing (NGS) panel of common cancer-associated genes, 25 leiomyosarcomas arising from multiple sites were examined to explore genetic alterations, including single nucleotide variants (SNV), small insertions/deletions (indels), and copy number alterations (CNA). Sequencing showed 86...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
